Combined Modality Therapy of Esophageal Cancer

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2008Publisher:Harborside Press, LLCJournal:Journal of the National Comprehensive Cancer Network, volume 6, pages 851-861 (issn: 1540-1405, eissn: 1540-1413,

Copyright policy )

Authors: Rosalyn A, Juergens; Arlene, Forastiere;

doi: 10.6004/jnccn.2008.0063

pmid: 18926094

Combined Modality Therapy of Esophageal Cancer

- Summary
- Subjects
- Metrics

Abstract

Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multimodality approaches to the management of esophageal cancer.

Related Organizations

Johns Hopkins University
United States
Sidney Kimmel Comprehensive Cancer Center
United States
Johns Hopkins Medicine
United States

Keywords

Esophageal Neoplasms, Adenocarcinoma, Combined Modality Therapy, Survival Analysis, Neoadjuvant Therapy, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Humans, Neoplasm Staging

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	17
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%